Pinkas Jan
SEC insider (Form 3/4/5 filer). CIK 0002077126. Chief Scientific Officer at CRESCENT BIOPHARMA, INC. (CBIO). 5 reported Form 4/5 transactions since Sep 2024; latest on Sep 16, 2026. Located in WALTHAM, MA.
Companies Pinkas Jan has filed insider reports for
- CRESCENT BIOPHARMA, INC. (CBIO): Officer, Chief Scientific Officer
Pinkas Jan
CIK: 0002077126
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (40.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CBIO
CRESCENT BIOPHARMA, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 16, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect658 shares at avg. $17.90$12K - Jun 22, 2026CBIO
CRESCENT BIOPHARMA, INC.
SaleDirect1.3K shares at avg. $17.99$23K - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirect17.5K shares- - Dec 15, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirect5K shares- - Jul 16, 2025CBIO
CRESCENT BIOPHARMA, INC.
AwardDirectStock Option (Right to Buy)
142.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 | CBIO CRESCENT BIOPHARMA, INC. | Sale | 658 | $17.90 | $11,778 | Direct |
| Jun 22, 2026 | CBIO CRESCENT BIOPHARMA, INC. | Sale | 1,288 | $17.99 | $23,171 | Direct |
| Dec 15, 2025 | CBIO CRESCENT BIOPHARMA, INC. | Award | 17,507 | - | - | Direct |
| Dec 15, 2025 | CBIO CRESCENT BIOPHARMA, INC. | Award | 5,000 | - | - | Direct |
| Jul 16, 2025 | CBIO CRESCENT BIOPHARMA, INC. | Award Stock Option (Right to Buy) | 142,474 | - | - | Direct |
1-5 of 5 transactions